S6K Promotes Dopaminergic Neuronal Differentiation Through PI3K/Akt/mTOR-Dependent Signaling Pathways in Human Neural Stem Cells

被引:28
|
作者
Lee, Jeong Eun [1 ,3 ]
Lim, Mi Sun [1 ,2 ]
Park, Jae Hyun [1 ,3 ]
Park, Chang Hwan [1 ,2 ]
Koh, Hyun Chul [1 ,3 ]
机构
[1] Hanyang Univ, Hanyang Biomed Res Inst, Seoul 133791, South Korea
[2] Hanyang Univ, Grad Sch Biomed Sci & Engn, Seoul 133791, South Korea
[3] Hanyang Univ, Dept Pharmacol, Coll Med, Seoul 133791, South Korea
关键词
S6K; PI3K/Akt/mTOR signaling; Human neural stem cells; Proliferation; Dopaminergic neuronal differentiation; GROWTH-FACTOR-I; KINASE-B-GAMMA; PROTEIN-KINASE; MAMMALIAN TARGET; IGF-I; RAPAMYCIN PATHWAY; BRAIN SIZE; INSULIN; NEUROGENESIS; MTOR;
D O I
10.1007/s12035-015-9325-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
It has recently been reported that the phosphoinositide 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) signaling pathway regulates neuronal differentiation of neural stem cells (NSCs) derived from rats or mice and is essential for the self-renewal of human embryonic stem cells (hESCs). However, the roles of PI3K/Akt/mTOR signaling pathways during proliferation and dopaminergic neuronal differentiation of human neural stem cells (hNSCs) are poorly understood. In this study, we examined the effect of regulation of these intracellular signaling pathways in hNSCs on the potential to maintain proliferation and induce dopaminergic neuronal differentiation. Dopaminergic neuronal differentiation depended on the concentration of insulin in our culture system. Inhibition of PI3K/Akt with LY294002 reduced proliferation and inhibited dopaminergic neuronal differentiation of these cells. We also found that rapamycin, a specific inhibitor of mTOR, significantly reduced neuronal differentiation without affecting proliferation. Inhibition of the Akt/mTOR signaling pathway led to inhibition of p70 ribosomal S6 kinase (S6K) signaling, which reduced dopaminergic neuronal differentiation in hNSCs. Inhibition of S6K by a specific chemical inhibitor, PF-4708671 inhibited dopaminergic neuronal differentiation of hNSCs. As expected, transduction with a dominant negative S6K1 (S6K1-DN) construct impaired dopaminergic neuronal differentiation of hNSCs. Conversely, overexpression of constitutively active S6K1 (S6K1-CA) promoted dopaminergic neuronal differentiation of these cells. In a survival study, 4 weeks after transplantation, no or very few donor cells were viable in striata grafted with S6K1-DN-transduced hNSCs. In contrast, S6K1-CA-transduced hNSCs survived, integrated into striata to generate tubular masses of grafts and differentiated toward TH-positive cells. Taken together, these data demonstrated that insulin promotes dopaminergic neuronal differentiation through a PI3K/Akt/mTOR-dependent pathway and that S6K plays a critical role in dopaminergic neuronal differentiation in hNSCs.
引用
收藏
页码:3771 / 3782
页数:12
相关论文
共 50 条
  • [1] S6K Promotes Dopaminergic Neuronal Differentiation Through PI3K/Akt/mTOR-Dependent Signaling Pathways in Human Neural Stem Cells
    Jeong Eun Lee
    Mi Sun Lim
    Jae Hyun Park
    Chang Hwan Park
    Hyun Chul Koh
    Molecular Neurobiology, 2016, 53 : 3771 - 3782
  • [2] PTEN Promotes Dopaminergic Neuronal Differentiation Through Regulation of ERK-Dependent Inhibition of S6K Signaling in Human Neural Stem Cells
    Lee, Jeong Eun
    Lim, Mi Sun
    Park, Jae Hyeon
    Park, Chang Hwan
    Koh, Hyun Chul
    STEM CELLS TRANSLATIONAL MEDICINE, 2016, 5 (10) : 1319 - 1329
  • [3] PI3K/AKT/mTOR Signaling and Differentiation of Human iPS Cells
    Cross, Alan
    Jaishankar, Amritha
    Brandon, Nicholas
    Wesolowski, Steve
    Burli, Roland
    Hoeppner, Dan
    Kim, Suel-Kee
    Seo, Seungmae
    Shin, Joo Heon
    Colantuoni, Carlo
    Chenoweth, Josh
    Weinberger, Daniel
    McKay, Ron
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S541 - S542
  • [4] PI3K/AKT/mTOR Signaling Mediates Valproic Acid-Induced Neuronal Differentiation of Neural Stem Cells through Epigenetic Modifications
    Zhang, Xi
    He, Xiaosong
    Li, Qingqing
    Kong, Xuejian
    Ou, Zhenri
    Zhang, Le
    Gong, Zhuo
    Long, Dahong
    Li, Jianhua
    Zhang, Meng
    Ji, Weidong
    Zhang, Wenjuan
    Xu, Liping
    Xuan, Aiguo
    STEM CELL REPORTS, 2017, 8 (05): : 1256 - 1269
  • [5] Icariside II promotes the osteogenic differentiation of canine bone marrow mesenchymal stem cells via the PI3K/AKT/mTOR/S6K1 signaling pathways
    Luo, Guangming
    Xu, Biao
    Huang, Yuanliang
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2017, 9 (05): : 2077 - 2087
  • [6] PI3K/AKT/MTOR SIGNALING IN OLIGODENDROCYTE DIFFERENTIATION
    Wood, T. L.
    Tyler, W. A.
    Gangoli, N.
    Gokina, P.
    Kim, H. A.
    Covey, M.
    Levison, S. W.
    JOURNAL OF NEUROCHEMISTRY, 2009, 110 : 141 - 141
  • [7] PI3K/AKT and mTOR/p70S6K1 Signaling Pathways in Human Cancer
    Jiang, Bing-Hua
    CURRENT CANCER DRUG TARGETS, 2013, 13 (03) : 233 - 233
  • [8] PI3K/Akt/mTOR signaling pathway in cancer stem cells
    Fath, Mohsen Karami
    Ebrahimi, Menooa
    Nourbakhsh, Ehsan
    Hazara, Ahmad Zia
    Mirzaei, Ali
    Shafieyari, Saba
    Salehi, Azadeh
    Hoseinzadeh, Mahsa
    Payandeh, Zahra
    Barati, Ghasem
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 237
  • [9] mTOR-Dependent and Independent Survival Signaling by PI3K in B Lymphocytes
    Kaileh, Mary
    Vazquez, Estefania
    MacFarlane, Alexander W.
    Campbell, Kerry
    Kurosaki, Tomohiro
    Siebenlist, Ulrich
    Sen, Ranjan
    PLOS ONE, 2016, 11 (01):
  • [10] IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways
    Shiyu Duan
    Wenqing Huang
    Xiaoting Liu
    Xuming Liu
    Nana Chen
    Qiong Xu
    Yukun Hu
    Wen Song
    Jun Zhou
    Journal of Experimental & Clinical Cancer Research, 37